Our aim is to become the world’s premier provider of neurovisual data for researchers, neuro-ophthalmologists, neuro-optometrists, ophthalmologists, optometrists and neurologists.
We provide an neurovisual data platform and a diagnostic support device that automates and quantifies data of neurovisual tests for the early detection of ophthalmological, neurological & psychological disorders.
Our unique BulbiHUB platform and BulbiCAM offers the user multiple neurovisual tests of which the outcome can be assessed in our platform, making it possible to rapidly and objectively add data of neurovisual examinations to your diagnostic workflow. As a researcher you can even co-create a test which you can commercialize through our platform.
In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the eye care professional is working remotely.
Ultimately our platform and BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s comprehensive ophthalmological, neurological and psychological condition.
We provide an neurovisual data platform and a diagnostic support device that automates and quantifies data of neurovisual tests for the early detection of ophthalmological, neurological & psychological disorders.
Our unique BulbiHUB platform and BulbiCAM offers the user multiple neurovisual tests of which the outcome can be assessed in our platform, making it possible to rapidly and objectively add data of neurovisual examinations to your diagnostic workflow. As a researcher you can even co-create a test which you can commercialize through our platform.
In addition results can be shared amongst clinicians through our telemedicine functionality, facilitating the patient to undergo the examination at a physical location while the eye care professional is working remotely.
Ultimately our platform and BulbiCAM requires the patient to do the work, can be operated by anyone and generates objective clinical results needed to fully assess the patient’s comprehensive ophthalmological, neurological and psychological condition.
Location: Norway, Trondheim
Employees: 11-50
Founded date: 2015
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 10.06.2022 | 42 start-ups through to Catapult 2022-23 semifinals | We are excited to today announce the 42 promising start-ups that will go through to the semifinals of EIT Health Catapult 2022-23. Each year, the competition showcases Europe’s most promising biotech, medtech and digital health start-ups to... |